General
Pfizer says trials show COVID-19 antiviral pill cuts hospitalisation and death risk by nearly 90 per cent
Pfizer says its experimental antiviral pill for COVID-19 cut rates of hospitalisation and death by nearly 90 per cent in high-risk adults, as the drugmaker joined the race for an easy-to-use medication to treat the coronavirus.
Key points:
- Pfizer says preliminary results of its study show its…
Continue Reading
-
Noosa News24 hours agoWoman dead and man rushed to hospital with gunshot wound following crash near Aussie World on Queensland’s Sunshine Coast
-
General22 hours agoSummah Richards, 12, mourned after fatal e-scooter in Laidley, Queensland
-
Noosa News24 hours agoMan arrested after police chase: Driver shot, woman dies in crash
-
General23 hours agoBoy’s drowning adds to ‘most horrific’ Easter toll